levetiracetam
(Levetiracetam)Tris Pharma Inc
Usage: Levetiracetam is indicated for treating partial-onset seizures in patients aged 1 month and older. It is also approved as adjunctive therapy for myoclonic seizures in patients aged 12 and older with juvenile myoclonic epilepsy, and for primary generalized tonic-clonic seizures in patients aged 6 and older with idiopathic generalized epilepsy.